Arcturus Therapeutics Holdings Inc. Common Stock

ARCT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
ARCT Income Statement
ARCT Balance Sheet
ARCT Cash Flow
Congress Trading

Recent trades of ARCT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ARCT Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
ARCT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ARCT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by ARCT's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $20,000 Jul 17, 2021 Issue: Health Issues Medicare/Medicaid
  • $20,000 Apr 19, 2021 Issue: Health Issues Medicare/Medicaid
  • $90,000 Jan 19, 2021 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $100,000 Oct 25, 2020 Issue: Medical/Disease Research/Clinical Labs
  • $80,000 Oct 19, 2020 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
  • $30,000 Apr 17, 2020 Issue: Medical/Disease Research/Clinical Labs
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Lipid particles for nucleic acid delivery Sep. 10, 2024
  • Patent Title: Synthetic transfer rna with extended anticodon loop Sep. 03, 2024
  • Patent Title: Nucleic acids and methods of treatment for cystic fibrosis Aug. 27, 2024
  • Patent Title: Compositions and methods for treating phenylketonuria Mar. 26, 2024
  • Patent Title: Translatable molecules and synthesis thereof Mar. 26, 2024
  • Patent Title: Lipid nanoparticles encapsulation of large rna Mar. 26, 2024
  • Patent Title: Compositions and methods for inducing immune responses Sep. 19, 2023
  • Patent Title: Coronavirus vaccine compositions and methods Sep. 05, 2023
  • Patent Title: Method of making lipid-encapsulated rna nanoparticles Aug. 29, 2023
  • Patent Title: Molecules and agents for treating hepatitis b virus Jun. 27, 2023
  • Patent Title: Compositions and methods for treating ornithine transcarbamylase deficiency Jun. 27, 2023
  • Patent Title: Ionizable cationic lipid for rna delivery Oct. 04, 2022
  • Patent Title: Synthetic transfer rna with extended anticodon loop Sep. 06, 2022
  • Patent Title: Translatable molecules and synthesis thereof Aug. 09, 2022
  • Patent Title: Synthesis and structure of high potency rna therapeutics May. 25, 2021
  • Patent Title: Ionizable cationic lipid for rna delivery Apr. 20, 2021
  • Patent Title: Compositions and agents against hepatitis b virus and uses thereof Mar. 30, 2021
  • Patent Title: Ionizable cationic lipid for rna delivery Mar. 30, 2021
  • Patent Title: Messenger una molecules and uses thereof Oct. 27, 2020
  • Patent Title: Method of synthesis of an ionizable cationic lipid Sep. 22, 2020
  • Patent Title: Acyl-amino-lna and/or hydrocarbyl-amino-lna oligonucleotides Aug. 04, 2020
  • Patent Title: Una oligomers having reduced off-target effects in gene silencing Jun. 16, 2020
  • Patent Title: Ionizable cationic lipid for rna delivery Feb. 11, 2020
  • Patent Title: Ionizable cationic lipid for rna delivery Jan. 07, 2020
  • Patent Title: Therapeutic una oligomers and uses thereof Dec. 31, 2019
  • Patent Title: Trinucleotide mrna cap analogs Nov. 26, 2019
  • Patent Title: Una oligomers for therapeutics with prolonged stability Oct. 29, 2019
  • Patent Title: Una oligomers and compositions for treating amyloidosis Sep. 24, 2019
  • Patent Title: Ionizable cationic lipid for rna delivery Sep. 03, 2019
  • Patent Title: Ionizable cationic lipid for rna delivery Aug. 20, 2019
  • Patent Title: Allele selective gene editing and uses thereof Aug. 06, 2019
  • Patent Title: Aromatic ionizable cationic lipid Mar. 19, 2019
  • Patent Title: Ionizable cationic lipid for rna delivery Mar. 12, 2019
  • Patent Title: Transthyretin allele selective una oligomers for gene silencing May. 29, 2018
  • Patent Title: Multiligand agent for drug delivery May. 08, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Apr. 24, 2018
  • Patent Title: Una single stranded oligomers for therapeutics Apr. 17, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Feb. 20, 2018
  • Patent Title: Formulations for treating amyloidosis Jan. 02, 2018
  • Patent Title: Ionizable cationic lipid for rna delivery Dec. 26, 2017
  • Patent Title: Aromatic ionizable cationic lipid Dec. 05, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Jun. 06, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Mar. 14, 2017
  • Patent Title: Lipid particles with asymmetric cationic lipids for rna delivery Feb. 28, 2017
  • Patent Title: Ionizable cationic lipid for rna delivery Feb. 14, 2017
  • Patent Title: Asymmetric ionizable cationic lipid for rna delivery Jun. 14, 2016
  • Patent Title: Una oligomer structures for therapeutic agents May. 17, 2016
  • Patent Title: Una duplex oligomers for therapeutics Apr. 05, 2016
  • Patent Title: Una oligomers targeting micro-rna for therapeutics Mar. 29, 2016
  • Patent Title: Una oligomers for therapeutics Jun. 09, 2015
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of ARCT in WallStreetBets Daily Discussion

ARCT News

Recent insights relating to ARCT

CNBC Recommendations

Recent picks made for ARCT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ARCT

ARCT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ARCT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top